Pharmaceutical Industry

Assing is the ideal partner for designing and manufacturing for Pharmaceutical production department, Bulk and Finishing, a sector where we have gained a solid experience over the years by collaborating with leading pharmaceutical brands.

Starting from the analysis of production processes, Assing is able to deal pharmaceutical projects, at 360°, Class A-B-C-D production departments  according to GMP and FDA in force, fully compliant with sectoral plant regulations and the design of areas at  ATEX explosion risk of.

Assing is able to design and realize:

  • Warehouses of raw materials and finished products.
  • Sampling areas.
  • Preparation rooms.
  • Powders departments.
  • Liquid departments (sterile, syrups).
  • Packaging departments.
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

Advanced Therapies and Medical Application

In the field of advanced therapies, Assing has developed a high quality know-how in the design and implementation of “cell factory” and biobanks for advanced therapy, transplant and regenerative medicine applications.

Assing has designed and built the first laboratories in Italy certified and authorized by AIFA (Italian Pharmaceutical Agency) as “pharmaceutical workshops” for advanced therapies.

In the field of Medical Applications, Assing provides a complete service for the design, implementation and management of hospital departments and facilities such as:

  • Hospital pharmacies for parenteral, antiblastic and radiopharmaceutical preparations.
  • Special intensive departments for the isolation of infective patients or immunodepressed patients.
  • Operating rooms and sterile areas with laminar flow systems.

In this area, Assing can rely on consolidated knowledge and experience through Cat Medical Systems (Assing Division), which designs, builds, installs, and keeps the service for the medical diagnostic systems.

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

Biological Containement

As part of the biological containment, Assing designs and manufactures Level 2, 3 and 4 Biosecurity Laboratories (PCL-BSL) for pathogen material research and bioengineering applications (MOGM) , with systems and facilities that ensure safety and reliability, both during operational phases and in maintenance activities.

Assing has gained a specific experience in the design and manufacture of laboratories at Maximum Level Biological Containment 4 (BSL4-PCL4) also with container structures. These structures, which are absolutely suitable for level 4 virus confinement (Ebola virus, Lassa virus, Crimea-Congo hemorrhagic fever etc.), are fully and technologically advanced environments that can be achieved in a short time and are equipped for rapid molecular diagnosis Ebola virus, both for the virological, immunologic and epidemiological studies needed to track the course of the infection in a post-Ebola phase.

Among the biological containment laboratories, Assing also includes the design and construction of animal house for research activity.

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